Lifetime costs of alcohol consumption in Thailand: protocol for an incidence-based cost-of-illness study using Markov model

被引:0
|
作者
Luangsinsiri, Chaisiri [1 ,2 ]
Thavorncharoensap, Montarat [3 ,4 ]
Chaikledkaew, Usa [3 ,4 ]
Pattanaprateep, Oraluck [5 ]
Sornpaisarn, Bundit [2 ,6 ]
Rehm, Jurgen [2 ,6 ]
机构
[1] Mahidol Univ, Fac Pharm, Dept Pharm, Philosophy Program Social Econ & Adm Pharm, Bangkok, Thailand
[2] Inst Mental Hlth Policy Res, Ctr Addict & Mental Hlth, Toronto, ON, Canada
[3] Mahidol Univ, Fac Pharm, Dept Pharm, Social & Adm Pharm Excellence Res SAPER Unit, Bangkok, Thailand
[4] Mahidol Univ Hlth Technol Assessment MUHTA, Int Grad Program, Mahidol Univ, Bangkok, Thailand
[5] Mahidol Univ, Fac Med, Dept Clin Epidemiol & Biostat, Ramathibodi Hosp, Bangkok, Thailand
[6] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
来源
BMJ OPEN | 2024年 / 14卷 / 04期
关键词
HEALTH ECONOMICS; Economics; Ethanol; Risk Factors;
D O I
10.1136/bmjopen-2023-079829
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Several prevalence-based cost-of-illness (COI) studies have been conducted to estimate the economic burden of alcohol consumption borne by a particular society in a given year. Yet there are few studies examining the economic costs incurred by an individual drinker over his/her lifetime. Thus, this study aims to estimate the costs incurred by an individual drinker's alcohol consumption over his or her lifetime in Thailand. Methods and analysis An incidence-based COI approach will be employed. To project individuals' associated costs over a lifetime, a Markov modelling technique will be used. The following six alcohol-related diseases/conditions will be considered in the model: hypertension, haemorrhagic stroke, liver cirrhosis, liver cancer, alcohol use disorders and road injury. The analysis will cover both direct (ie, direct healthcare cost, costs of property damage due to road traffic accidents) and indirect costs (ie, productivity loss due to premature mortality and hospital-related absenteeism). The human capital approach will be adopted to estimate the cost of productivity loss. All costs will be presented in Thai baht, 2022. Ethics and dissemination The Institutional Review Board of Mahidol University, Faculty of Dentistry/Faculty of Pharmacy has confirmed that no ethical approval is required (COE.No.MU-DT/PY-IRB 2021/010.0605). Dissemination of the study findings will be carried out through peer-reviewed publications, conferences and engagement with policy-makers and public health stakeholders.
引用
收藏
页数:6
相关论文
共 25 条
  • [21] Estimating the Incidence-Based Cost of Illness Due to Hematopoietic Stem Cell Transplantation Using One-Year Insurance Claim Data in Korea
    Kwon, Sol
    Kang, Hye-Young
    PHARMACOECONOMICS-OPEN, 2023, 7 (02) : 189 - 197
  • [22] Estimating the Incidence-Based Cost of Illness Due to Hematopoietic Stem Cell Transplantation Using One-Year Insurance Claim Data in Korea
    Sol Kwon
    Hye-Young Kang
    PharmacoEconomics - Open, 2023, 7 : 189 - 197
  • [23] A PROSPECTIVE, MULTI-CENTRE, PREVALENCE-BASED COST-OF-ILLNESS STUDY OF RA IN THE UK. RELATIVE COSTS OF BIOLOGICS AND ORTHOPAEDIC SURGERY IN ESTABLISHED DISEASE
    Nikiphorou, E.
    Morris, S.
    MacGregor, A.
    Cooper, N.
    Chipping, J.
    Symmons, D.
    Young, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 341 - 342
  • [24] Efficacy and cost-effectiveness of a community-based model of care for older patients with complex needs: a study protocol for a multicentre randomised controlled trial using a stepped wedge cluster design
    Kinchin, Irina
    Jacups, Susan
    Mann, Jennifer
    Quigley, Rachel
    Harvey, Desley
    Doran, Christopher M.
    Strivens, Edward
    TRIALS, 2018, 19
  • [25] Efficacy and cost-effectiveness of a community-based model of care for older patients with complex needs: a study protocol for a multicentre randomised controlled trial using a stepped wedge cluster design
    Irina Kinchin
    Susan Jacups
    Jennifer Mann
    Rachel Quigley
    Desley Harvey
    Christopher M. Doran
    Edward Strivens
    Trials, 19